Brief: Edgewise Provides Statement Regarding Company’S Relationship With Dr. Han Phan

Edgewise Therapeutics

05/12/2024 19:36

Dec 5 (Reuters) - Edgewise Therapeutics Inc  EWTX.O :
    * EDGEWISE PROVIDES STATEMENT REGARDING COMPANY’S
RELATIONSHIP
WITH DR. HAN PHAN AT RARE DISEASE RESEARCH
    * EDGEWISE THERAPEUTICS-  BELIEVES DATA RELATED TO CO'S
CLINICAL
TRIALS AT PHAN'S SITE ARE ACQUIRED & STORED IN ACCORDANCE WITH
FDA REQUIREMENTS
    * EDGEWISE THERAPEUTICS: WARNING LETTER BY FDA TO DR. HAN
PHAN IS
UNRELATED TO ANY EDGEWISE CLINICAL TRIAL OR DATA

Source text:  ID:nBw64fywa 
Further company coverage:  EWTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))